Pathological arterial muscularization and the role of integrins
病理性动脉肌化和整合素的作用
基本信息
- 批准号:8969702
- 负责人:
- 金额:$ 41.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-11-17 至 2018-10-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsAdhesionsAortaAortic Valve StenosisArterial DisorderArterial MediasArteriesAtherosclerosisAttenuatedBlood VesselsBlood flowCaliberCardiovascular DiseasesCell Differentiation processCell ProliferationCellsCytoskeletonDiseaseDistalDown-RegulationElastinEmbryoEndothelial CellsExtracellular MatrixGene DosageGenesGeneticGoalsGrowthHealthHomeoboxHumanInjuryIntegrin beta3IntegrinsInterventionKnockout MiceLinkLongevityLungMapsMediatingMitogensModelingMolecularMusMutant Strains MiceOperative Surgical ProceduresPathogenesisPathologyPericytesPhenotypePlaguePopulationPulmonary HypertensionRegulationRoleSeriesSignal TransductionSmooth MuscleSmooth Muscle MyocytesSourceStenosisStimulusSumSupravalvular aortic stenosisTestingTissuesTransgenic OrganismsTunica MediaUp-RegulationVascular DiseasesVascular Smooth MuscleWorkarteriolecell motilitycombatdosageeffective therapyhuman diseasein vivoinduced pluripotent stem cellinjuredloss of function mutationmigrationmouse modelmutantnovelnovel therapeuticsnull mutationoverexpressionpostnatalpreventpupreceptorresponserestenosistranscription factor
项目摘要
DESCRIPTION (provided by applicant): Cardiovascular diseases exert a massive burden on human health, and our long term objective is to attenuate the excessive accumulation of vascular smooth muscle cells (VSMCs) that is central to many of these diseases. The tunica media of the normal artery is composed of alternating circumferential layers of VSMCs and elastic lamellae. Diverse arterial disorders, including atherosclerosis, restenosis, pulmonary hypertension and supravalvular aortic stenosis (SVAS) are plagued by defective elastic lamellae as well as hypermuscularization. SVAS, a devastating human disease characterized by an increased VSMC burden that occludes large arteries, is caused by heterozygous null mutations in the elastin gene ELN. Similarly, elastin mutant mice develop hypermuscularization and stenosis of large arteries, such as the aorta. Major vascular surgery is the only current treatment
for SVAS as no effective pharmacological options are available. A major obstacle to developing effective therapies for vascular disorders is the poor understanding of the cellular source(s) of excess VSMCs; indeed no prior studies have traced the lineage of any cell populations in elastin mutants. In addition, the molecular and cellular mechanisms underlying aortic hypermuscularization in elastin mutants are not well defined. Our initial studies indicate that integrin �expression and integrin signaling is robustly upregulated in the elastin mutant aorta and that reduction of �levels or activity attenuates the excessive muscularization. Furthermore, reduction of the dosage of the gene encoding � Itgb3, extends the viability of Eln(-/-) pups which is unprecedented for any genetic or pharmacological intervention. A potentially attractive strategy for reducing arterial hypermuscularization in SVAS is attenuating the increased �expression. Although little is known regarding regulation of �expression, the growth arrest-specific homeobox (Gax) transcription factor is expressed in VSMCs and Gax overexpression reduces �levels, proliferation and migration. We hypothesize that in elastin mutants, Gax downregulation induces integrin �expression in pre-existing aortic smooth muscle resulting in aberrant VSMC orientation, proliferation and migration and thus aortic stenosis. This proposal utilizes studies of transgenic mutant mice, VSMCs isolated from the murine aorta and human SVAS aortic tissue and cells to test this hypothesis in three specific aims: 1) in the elastin mutant aorta, identify the cellular source(s) of excessive VSMCs; 2) in elastin deficient mice, murine VSMCs and human SVAS-derived smooth muscle cells, elucidate the molecular and cellular mechanisms underlying integrin �induced excess aortic muscularization; and 3) elucidate the role of Gax in mediating enhanced integrin �expression and hypermuscularization in elastin mutants. Taken together, our proposed studies will delineate mechanisms underlying the identified link between elastin deficiency, integrin �and aortic hypermuscularization and thereby provide concrete steps towards developing novel therapeutic strategies for SVAS and other vasculoproliferative diseases.
描述(由申请人提供):心血管疾病对人类健康造成巨大负担,我们的长期目标是减轻血管平滑肌细胞(VSMCs)的过度积累,这是许多这些疾病的核心。正常动脉的中膜由VSMCs的周向层和弹性片层交替组成。多种动脉疾病,包括动脉粥样硬化、再狭窄、肺动脉高压和瓣上主动脉狭窄(SVAS),都是由弹性瓣片缺陷和肌肉肥大所困扰的。SVAS是一种破坏性的人类疾病,其特征是VSMC负担增加,阻塞大动脉,是由弹性蛋白基因ELN的杂合零突变引起的。同样,弹性蛋白突变小鼠也会出现肌肉肥大和大动脉(如主动脉)狭窄。大血管手术是目前唯一的治疗方法
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel Greif其他文献
Daniel Greif的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel Greif', 18)}}的其他基金
Epigenetic-mediated Notch pathway activation promotes elastin aortopathy
表观遗传介导的Notch通路激活促进弹性蛋白主动脉病
- 批准号:
10595308 - 财政年份:2023
- 资助金额:
$ 41.63万 - 项目类别:
Pericyte angiopoietin2 and neonatal intracranial hemorrhage
周细胞血管生成素2与新生儿颅内出血
- 批准号:
10288547 - 财政年份:2021
- 资助金额:
$ 41.63万 - 项目类别:
Novel vascular smooth muscle cell progenitors in development and disease
发育和疾病中的新型血管平滑肌细胞祖细胞
- 批准号:
10670304 - 财政年份:2020
- 资助金额:
$ 41.63万 - 项目类别:
Novel vascular smooth muscle cell progenitors in development and disease
发育和疾病中的新型血管平滑肌细胞祖细胞
- 批准号:
9893632 - 财政年份:2020
- 资助金额:
$ 41.63万 - 项目类别:
Novel vascular smooth muscle cell progenitors in development and disease
发育和疾病中的新型血管平滑肌细胞祖细胞
- 批准号:
10433824 - 财政年份:2020
- 资助金额:
$ 41.63万 - 项目类别:
Vascular disease pathogenesis: the interface of smooth muscle and immune cells
血管疾病发病机制:平滑肌与免疫细胞的界面
- 批准号:
9769127 - 财政年份:2018
- 资助金额:
$ 41.63万 - 项目类别:
Pathological arterial muscularization and the role of integrins
病理性动脉肌化和整合素的作用
- 批准号:
8800479 - 财政年份:2014
- 资助金额:
$ 41.63万 - 项目类别:
Mural cell TGF-beta-mediated signaling and neonatal intracerebral hemorrhage
壁细胞TGF-β介导的信号传导与新生儿脑出血
- 批准号:
8772010 - 财政年份:2014
- 资助金额:
$ 41.63万 - 项目类别:
Morphogenesis of the pulmonary artery smooth muscle layer
肺动脉平滑肌层的形态发生
- 批准号:
8308488 - 财政年份:2008
- 资助金额:
$ 41.63万 - 项目类别:
Morphogenesis of the pulmonary artery smooth muscle layer
肺动脉平滑肌层的形态发生
- 批准号:
8212890 - 财政年份:2008
- 资助金额:
$ 41.63万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 41.63万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 41.63万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 41.63万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 41.63万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 41.63万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 41.63万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 41.63万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 41.63万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 41.63万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 41.63万 - 项目类别: